GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Access Bio (XKRX:950130) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Sep. 22, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Access Bio's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Access Bio's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Access Bio's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Access Bio's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Access Bio's Future 3-5Y EPS without NRI Growth Rate falls into.


Access Bio  (XKRX:950130) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Access Bio Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Access Bio's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XKRX:461030 XKRX:084650 XKRX:038290 XKRX:217330 XKRX:180400 XKRX:253840 XKRX:384470 XKRX:950200 XKRX:109820 XKRX:153710 TMO DHR XSWX:LONN IQV A IDXX MTD ICLR ILMN WAT
Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Website
http://www.accessbio.net
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio Headlines

No Headlines